Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6

Publication Title

60th ERA Congress 2023

Document Type

Presentation

Publication Date

6-2023

Keywords

washington; spokane; pmrc

Clinical Institute

Kidney & Diabetes

Specialty

Nephrology

Specialty

Endocrinology

Comments

Bain SC, Bosch-Traberg H, Cherney D, Rasmussen S, Sokareva K, Khunti K, Tuttle KR

This document is currently not available here.


Share

COinS